Proteins: Folding and misfolding | Biotechnology

 Proteins: Folding and misfolding 

Biotechnology

### Proteins: Folding and Misfolding

**Protein Folding**

Protein folding is the process by which a linear polypeptide chain acquires its three-dimensional native structure, which is essential for biological function. The folding information is encoded in the amino acid sequence, as demonstrated by Anfinsen's dogma. Folding occurs through a hierarchical pathway: secondary structures (α-helices, β-sheets) form first, followed by tertiary packing and, for multimeric proteins, quaternary assembly.

Many proteins fold cotranslationally with the help of **molecular chaperones** (e.g., Hsp70, GroEL/GroES) that prevent aggregation and provide a sheltered environment. Chaperonins form cage-like structures where folding occurs in isolation. Folding is thermodynamically driven by the hydrophobic effect—nonpolar residues burying in the core—and is balanced by hydrogen bonding, electrostatic interactions, and van der Waals forces. The energy landscape theory describes folding as a funnel-shaped surface guiding the polypeptide toward the native minimum.

**Protein Misfolding**

Misfolding occurs when a protein fails to achieve or maintain its native conformation, instead adopting aberrant structures rich in β-sheets. These misfolded species expose hydrophobic patches normally buried, leading to aggregation. Two common aggregation forms are:

- **Amorphous aggregates:** Disordered clumps, often degraded by cellular quality control.

- **Amyloid fibrils:** Highly ordered, β-sheet-rich filaments with a cross-β core. Amyloids are associated with devastating diseases.

**Consequences and Disease**

Misfolding underlies numerous human disorders, collectively termed **protein conformational diseases**:

- **Neurodegenerative:** Alzheimer's (Aβ amyloid, tau tangles), Parkinson's (α-synuclein Lewy bodies), Huntington's (huntingtin polyQ aggregates), and prion diseases (PrPᶜ → PrPˢᶜ).

- **Systemic amyloidosis:** Immunoglobulin light chains or transthyretin deposit in organs.

- **Loss-of-function:** Cystic fibrosis (CFTR misfolding leading to degradation) and alpha-1 antitrypsin deficiency.

**Cellular Protection**

Cells deploy chaperones, the ubiquitin-proteasome system, and autophagy to refold or degrade misfolded proteins. When these systems fail, toxic aggregates accumulate, driving pathology. Understanding folding and misfolding is critical for developing therapies—ranging from small-molecule chaperones (pharmacological chaperones) to enhancing proteostasis network activity.

Proteins: Amino acids and structural levels of proteins | Biotechnology

 Proteins: Amino acids and structural levels of proteins | Biotechnology

### Proteins: Amino Acids and Structural Levels

**Amino Acids: The Building Blocks**

Proteins are linear polymers composed of 20 standard L-α-amino acids. Each amino acid consists of a central carbon (Cα) bonded to an amino group (-NH₃⁺), a carboxyl group (-COO⁻), a hydrogen atom, and a variable side chain (R-group). The R-group determines chemical properties: nonpolar/hydrophobic (e.g., leucine, valine), polar uncharged (e.g., serine, glutamine), positively charged (lysine, arginine, histidine), or negatively charged (aspartate, glutamate). Amino acids link via **peptide bonds**—amide linkages formed by dehydration between the carboxyl group of one amino acid and the amino group of the next. This generates a polypeptide backbone with alternating N-Cα-C atoms, and side chains projecting outward.

**Levels of Protein Structure**

1. **Primary Structure:** The linear sequence of amino acids from N-terminus to C-terminus. This sequence encodes all higher-order structural information (Anfinsen's dogma). A single amino acid substitution (e.g., sickle-cell anemia: Glu6Val in hemoglobin) can cause dramatic functional consequences.

2. **Secondary Structure:** Local folding patterns stabilized primarily by hydrogen bonds between backbone amide and carbonyl groups. Common motifs include:

- **α-helix:** Right-handed coil with 3.6 residues per turn, stabilized by i → i+4 hydrogen bonds.

- **β-sheet:** Extended strands arranged laterally, either parallel or antiparallel, stabilized by inter-strand hydrogen bonds.

- **Turns and loops:** Connect secondary elements; β-turns reverse polypeptide direction.

3. **Tertiary Structure:** The three-dimensional global fold of a single polypeptide chain, stabilized by hydrophobic effect (core burial), hydrogen bonds, disulfide bridges (covalent between cysteine residues), electrostatic interactions (salt bridges), and van der Waals forces. Domains are independently folding structural units.

4. **Quaternary Structure:** The spatial arrangement of multiple polypeptide subunits (identical or different) into a functional multimeric protein. Stabilizing interactions are similar to tertiary. Examples include hemoglobin (α₂β₂ tetramer) and DNA polymerase.

Structural levels are hierarchical but interdependent; tertiary packing influences secondary element placement. Understanding these levels is fundamental for predicting function, designing mutants, and interpreting disease-causing mutations.

Genomics and Transcriptomics: Why proteomics? | Biotechnology

 Genomics and Transcriptomics: Why proteomics?  

Biotechnology

### Genomics and Transcriptomics: Why Proteomics?

Genomics and transcriptomics have revolutionized biology by providing static blueprints (DNA) and snapshots of gene expression (RNA). However, these approaches cannot fully predict protein abundance, function, or dynamics. Proteomics—the large-scale study of proteins—fills this critical gap for several fundamental reasons.

**1. RNA Does Not Equal Protein**

Due to post-transcriptional regulation, mRNA transcript levels correlate poorly with protein abundance (often R² < 0.4). Variability in translation efficiency, differential mRNA degradation, and ribosome occupancy mean that high transcript levels do not guarantee high protein expression. Proteomics directly measures the functional executors of the cell, not just their proxies.

**2. Post-Translational Modifications (PTMs)**

Genomes and transcriptomes carry no information about PTMs—phosphorylation, glycosylation, ubiquitination, acetylation, and over 400 others. PTMs dynamically regulate protein activity, localization, stability, and interactions. A protein may be present but inactive without phosphorylation; conversely, a low-abundance kinase can trigger massive signaling cascades. Proteomics uniquely detects and quantifies these modifications, revealing real-time regulatory states.

**3. Protein Turnover and Half-Life**

Transcripts have finite lifetimes, but proteins persist much longer. A stable protein may remain functional for days after its mRNA has vanished. Conversely, rapid protein degradation (e.g., cyclins) controls cell cycle progression. Only proteomics—especially using stable isotope labeling—can measure synthesis and degradation rates simultaneously.

**4. Subcellular Localization and Complexes**

A single gene product can localize to multiple compartments (nucleus, cytoplasm, membrane) or assemble into distinct protein complexes with divergent functions. Transcriptomics provides no spatial or interaction information. Proteomics, combined with fractionation or affinity purification, maps proteins to their sites of action.

**5. Isoforms and Truncations**

Alternative splicing produces protein variants, but mRNA isoforms are poor predictors of actual translated products. Proteomic peptides can distinguish functional variants arising from proteolytic processing (zymogen activation) or differential start sites.

**Conclusion**

Genomics tells us what *could* happen; transcriptomics suggests what *might* be happening; but proteomics reveals what *is* happening—the functional phenotype. Integrating all three layers provides a complete biological picture, but proteomics remains indispensable for understanding real-time cellular execution, regulation, and response to stimuli.

Central Dogma: Basics of DNA, RNA, Proteins | Biotechnology

Central Dogma: Basics of DNA, RNA, Proteins 

 Biotechnology

### Central Dogma: Basics of DNA, RNA, and Proteins

The **Central Dogma of Molecular Biology**, formulated by Francis Crick in 1958, describes the directional flow of genetic information within a biological system. It states that information passes from DNA to RNA to protein, and this transfer is generally irreversible.

**DNA: The Master Blueprint**

Deoxyribonucleic acid (DNA) is the long-term storage molecule of genetic information. It consists of two antiparallel polynucleotide strands wound into a double helix. Each nucleotide contains a deoxyribose sugar, a phosphate group, and one of four nitrogenous bases: adenine (A), thymine (T), guanine (G), or cytosine (C). Base pairing is specific: A pairs with T (two hydrogen bonds), and G pairs with C (three hydrogen bonds). The sequence of these bases encodes the instructions for building all cellular proteins. DNA resides primarily in the nucleus (in eukaryotes) and is replicated before cell division.

**RNA: The Messenger and Worker**

Ribonucleic acid (RNA) is typically single-stranded and uses ribose sugar with uracil (U) replacing thymine. Three major classes participate in information transfer:

- **mRNA (messenger RNA):** A complementary copy of a gene, transcribed from DNA. It carries the genetic code from the nucleus to ribosomes in the cytoplasm.

- **tRNA (transfer RNA):** Adaptor molecules that bring specific amino acids to the ribosome during protein synthesis.

- **rRNA (ribosomal RNA):** Catalytic and structural component of ribosomes.

**Proteins: The Functional Executors**

Proteins are polymers of amino acids linked by peptide bonds. The linear amino acid sequence (primary structure) folds into three-dimensional conformations (secondary, tertiary, quaternary) that determine function. Proteins serve as enzymes, structural scaffolds, signaling molecules, transporters, and regulators.

**The Two Key Processes**

1. **Transcription:** DNA is transcribed into RNA by RNA polymerase. A DNA segment (gene) serves as template to synthesize a complementary mRNA strand. In eukaryotes, pre-mRNA undergoes splicing (intron removal, exon joining) to produce mature mRNA.

2. **Translation:** The mRNA sequence is decoded by ribosomes to synthesize a polypeptide chain. Each triplet codon (three nucleotides) specifies one amino acid, following the genetic code—nearly universal and degenerate (multiple codons per amino acid).

The Central Dogma remains foundational, though exceptions exist (e.g., reverse transcription in retroviruses, prion propagation). Nonetheless, DNA → RNA → protein provides the core framework for understanding heredity, gene expression, and cellular function.

Introduction to Proteomics Course | Biotechnology

Introduction to Proteomics Course 

Biotechnology

### Introduction to Proteomics Course

**Course Overview**

This course provides a comprehensive introduction to proteomics—the large-scale study of proteins, their structures, functions, interactions, and dynamics within biological systems. Unlike genomics, which offers a static blueprint, proteomics captures the dynamic functional output of the cell. Students will explore the principles, methodologies, and applications of proteomics in biomedical research, biotechnology, and systems biology.

**Learning Objectives**

Upon completion, students will be able to:

- Explain the central dogma and the rationale for studying proteins directly.

- Design sample preparation protocols for diverse biological samples (tissues, serum, bacteria).

- Describe major proteomic technologies including two-dimensional electrophoresis (2-DE), mass spectrometry (MS), and protein microarrays.

- Interpret protein identification and quantitation data (label-free, SILAC, iTRAQ, TMT).

- Analyze post-translational modifications (PTMs) and protein-protein interactions.

- Apply proteomics tools to real-world problems such as biomarker discovery, drug target identification, and personalized medicine.

**Course Structure (Modular Outline)**

| Module | Topic |

| 1 | Basics of proteins, amino acids, and structural organization |

| 2 | Protein separation techniques: electrophoresis and chromatography |

| 3 | Mass spectrometry fundamentals (ionization, analyzers, detectors) |

| 4 | Quantitative proteomics and PTM analysis |

| 5 | Interactomics and structural proteomics |

| 6 | Bioinformatics and data analysis (database searching, statistics) |

| 7 | Applications in disease biology, microbiology, and systems biology |

**Teaching Methods**

The course combines lectures, hands-on laboratory sessions (protein extraction, 2-DE, MS sample preparation), computational tutorials (using tools like Mascot, MaxQuant, PEAKS, and R/Bioconductor for proteomics), and case study discussions. Students will complete a final project involving analysis of a published proteomic dataset.

**Who Should Enroll**

This course is designed for undergraduate and graduate students in biochemistry, molecular biology, biotechnology, and biomedical sciences, as well as researchers seeking to integrate proteomics into their work. No prior proteomics experience is required, but basic knowledge of protein chemistry is recommended.

By the end of this course, students will be equipped to critically evaluate proteomic literature, design sound experiments, and analyze complex protein datasets—skills essential for modern molecular life sciences.